The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 413.50
Bid: 414.00
Ask: 418.00
Change: 6.00 (1.47%)
Spread: 4.00 (0.966%)
Open: 411.00
High: 419.00
Low: 411.00
Prev. Close: 407.50
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Capital reduction following completion of program

26 Jan 2024 11:32

RNS Number : 0915B
Banco Santander S.A.
26 January 2024
HEADLINE ALTERATION

The headline for the Banco Santander, S.A. announcement released on 26 January 2024 at 11:19 under RNS No 0905B should read "Capital reduction following completion of program".

The announcement text is unchanged and is reproduced in full below.

Banco Santander, S.A. (the "Bank" or "Banco Santander"), in compliance with the securities market legislation, hereby communicates the following:

OTHER RELEVANT INFORMATION

Banco Santander share capital reduces by 2.22% following completion of buy-back programme

Reference is made to our notice of inside information of 27 September 2023 (official registry number 1979), relating to the buyback programme of own shares approved by the board of directors of Banco Santander (the "Buy-back Programme" or the "Programme"). The Bank informs that, after the last acquisitions mentioned below, the maximum investment provided for in the Buy-back Programme (i.e. EUR 1,310 million) has been reached, having acquired a total of 358,567,487 own shares, representing approximately 2.22% of the Bank's share capital. The acquisition of shares under the Buy-back Programme has been communicated on a regular basis, pursuant to the provisions of Articles 2.2 and 2.3 of the Commission Delegated Regulation (EU) No. 2016/1052. As a consequence of the above, the Buy-back Programme has been terminated in accordance with the terms set out when it was announced.

As disclosed when the Buy-back Programme was launched, the purpose of the Programme was to reduce the Bank's share capital by redeeming the shares acquired thereunder, which was authorised by the European Central Bank on 27 September 2023 (the "Capital Reduction"). The implementation of the Capital Reduction, which was approved at the Bank's ordinary general shareholders' meeting held on 31 March 2023 on second call under item 5 B of the agenda, is expected to take place at the meeting of the board of directors of the Bank to be held on 30 January 2024.

As a result of the Capital Reduction, Banco Santander's share capital will be reduced by EUR 179,283,744 through the cancellation of the aforementioned 358,567,487 own shares, each with a nominal value of EUR 0.50. Consequently, the Bank's share capital will be set at EUR 7,912,789,286, represented by 15,825,578,572 shares, all of them of the same class and series.

The purpose of the Capital Reduction is the cancellation of the own shares acquired under the Buy-back Programme, contributing to the remuneration of the Bank's shareholders by increasing the profit per share, which is inherent to the decrease in the number of shares. The Capital Reduction will not entail the return of contributions to shareholders, since the Bank is the owner of the shares to be cancelled.

It is expected that a reserve for amortised capital be created with a charge to the share premium reserve for an amount equal to the nominal value of the cancelled shares (i.e. EUR 179,283,744), which may only be used under the same conditions as those required for the reduction of the share capital, pursuant to the provisions of Article 335 c) of the Spanish Companies Law. Consequently, in accordance with the provisions of such Article, the Bank's creditors will not be afforded the right of objection referred to in Article 334 of the same Law.

For purposes of the provisions of Article 411 of the Spanish Companies Law and in accordance with Additional Provision One of Law 10/2014 of 26 June on the organisation, supervision and solvency of credit institutions, it is hereby stated for the record that, as the Bank is a credit institution and the other requirements set forth in the aforementioned Additional Provision are met, the consent of the bondholder syndicates for the outstanding debenture and bond issues is not required for the implementation of the reduction.

The announcements of the Capital Reduction will be published in the Official Gazette of the Spanish Commercial Registry and on the Bank's corporate website (www.santander.com) in the coming days.

Thereafter, the public deed regarding the corporate resolutions on the Capital Reduction and amendment of the Bank's By-laws will be granted and subsequently registered with the Commercial Registry of Santander. In addition, the delisting of the 358,567,487 cancelled shares from the Spanish and foreign stock exchanges or stock markets on which the Bank's shares are listed, and the cancellation of the book-entry records of the cancelled shares before the competent bodies will both be requested.

Accumulated share capital reduction resulting from the buyback programmes

After the completion of the Buy-back Programme, which will entail a share capital reduction of the Bank`s share capital by approximately 2.22%, once the five buyback programmes carried out against the 2021, 2022 and 2023 results have been completed the accumulated share capital reduction amounts to approximately EUR 758, with the Bank having repurchased almost 1,515,062,730 shares since November 2021, almost 9% of its outstanding shares as of that date.

Last transactions executed under the Programme

Moreover, pursuant to article 5 of Regulation (EU) no. 596/2014 on Market Abuse of 16 April 2014, and articles 2.2 and 2.3 of Commission Delegated Regulation (EU) 2016/1052, of 8 March 2016, the Bank informs, that it has carried out the following transactions over its own shares between 18 and 25 January 2024 (both inclusive):

Date

Security

Transaction

Trading venue

Number of shares

Weighted average price (?)

18/01/2024

SAN

Purchase

XMAD

6,000,000

3.7117

19/01/2024

SAN

Purchase

XMAD

1,000,000

3.7145

22/01/2024

SAN

Purchase

XMAD

2,495,257

3.7494

23/01/2024

SAN

Purchase

XMAD

2,000,000

3.6853

24/01/2024

SAN

Purchase

XMAD

6,120,000

3.7077

24/01/2024

SAN

Purchase

CEUX

1,380,000

3.7102

25/01/2024

SAN

Purchase

XMAD

4,556,819

3.6587

TOTAL

23,552,076

Issuer name: Banco Santander, S.A. - LEI 5493006QMFDDMYWIAM13

Reference of the financial instrument: ordinary shares - Code ISIN ES0113900J37

Detailed information of the transactions carried out within the referred period is attached as Annex I.

Boadilla del Monte (Madrid), 26 January 2024

ANNEX I

Detailed information on each of the transactions carried out within the context of the Buy-back Programme between 18/01/2024 and 25/01/2024 (both inclusive).

IMPORTANT INFORMATION

Not a securities offer

This document and the information it contains does not constitute an offer to sell nor the solicitation of an offer to buy any securities.

Past performance does not indicate future outcomes

Statements about historical performance or growth rates must not be construed as suggesting that future performance, share price or results (including earnings per share) will necessarily be the same or higher than in a previous period. Nothing in this document should be taken as a profit and loss forecast.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
POSEAFFKAAPLEFA
Date   Source Headline
26th Apr 202411:28 amRNSBuyback programme: transactions 18-25 Apr
23rd Apr 202411:03 amRNSNotice of First Quarter 2024 Results
18th Apr 202411:04 amRNSBuyback programme: transactions 11-17 Apr
11th Apr 202411:07 amRNSBuyback programme: transactions 3-10 Apr
3rd Apr 202411:10 amRNSBuyback programme: transactions 21Mar-2Apr
2nd Apr 20245:07 pmRNSTotal Voting Rights
22nd Mar 20242:27 pmRNS2024 AGM - Resolutions
22nd Mar 20247:00 amRNSSantander is on its track to meet its 2024 targets
21st Mar 202410:52 amRNSBuyback programme: transactions 14-20 Mar
19th Mar 20249:47 amRNS2023 UK Annual Report
18th Mar 20245:46 pmRNSDirector/PDMR Shareholding
18th Mar 20245:37 pmRNSDirector/PDMR Shareholding
18th Mar 20245:26 pmRNSDirector/PDMR Shareholding
14th Mar 202411:04 amRNSBuyback programme: transactions 7-13 Mar
12th Mar 20249:30 amRNSForm 8.3 - Spirent Communications plc
7th Mar 202411:05 amRNSBuyback programme: transactions 29 Feb-6 Mar
29th Feb 20242:50 pmRNSTotal Voting Rights
29th Feb 202411:07 amRNSBuyback programme: transactions 20-28 Feb
27th Feb 20245:15 pmRNSDirector/PDMR Shareholding
27th Feb 20245:13 pmRNSDirector/PDMR Shareholding
27th Feb 20245:12 pmRNSDirector/PDMR Shareholding
21st Feb 20243:33 pmRNSDirector/PDMR Shareholding
20th Feb 20247:00 amRNSNotice of AGM
19th Feb 202411:17 amRNSDividend approval & buyback program implementation
19th Feb 20247:45 amRNSFurther re dividend approval
19th Feb 20247:43 amRNSDividend approval & buyback program implementation
7th Feb 20244:39 pmRNSDirector/PDMR Shareholding
7th Feb 20244:38 pmRNSDirector/PDMR Shareholding
7th Feb 20244:36 pmRNSDirector/PDMR Shareholding
5th Feb 20245:48 pmRNSFurther re capital reduction
1st Feb 20244:46 pmRNSDirector/PDMR Shareholding
31st Jan 20243:55 pmRNSTotal Voting Rights
31st Jan 20247:00 amRNS2023 Results - Press release
31st Jan 20247:00 amRNS2023 Results Report & Earnings Presentation
26th Jan 202411:32 amRNSCapital reduction following completion of program
26th Jan 202411:19 amRNSTransaction in Own Shares
24th Jan 202411:06 amRNSNotice of 2023 Results Presentation
18th Jan 202411:05 amRNSBuyback programme: transactions 11-17 Jan
11th Jan 202411:08 amRNSBuyback programme: transactions 4-10 Jan
4th Jan 202411:07 amRNSBuyback programme: transactions 28 Dec- 3 Jan
29th Dec 202311:58 amRNSTotal Voting Rights
28th Dec 202311:08 amRNSBuyback programme: transactions 21-27 Dec
21st Dec 202311:07 amRNSBuyback programme: transactions 14-20 Dec
20th Dec 20234:14 pmRNSDirector/PDMR Shareholding
20th Dec 20237:00 amRNSAdapting reporting to new operating model (ppt)
20th Dec 20237:00 amRNSAdapting reporting to new operating model (PR)
18th Dec 20235:22 pmRNSDirector/PDMR Shareholding
18th Dec 20235:17 pmRNSDirector/PDMR Shareholding
18th Dec 20237:05 amRNSDirector/PDMR Shareholding
14th Dec 202311:05 amRNSBuyback programme: transactions 5-13 Dec

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.